The pharmaceutical industry is going through a period of increased regulatory action in the US and globally.
There have been significant financial judgments and criminal convictions through recent high-profile investigations and aggressive prosecutions. This trend is nudging pharmaceutical companies to respond strongly to implementing robust enterprise-wide pharma compliance management programs...